entertainment -WSS

entertainment

author：leisure time 2025-09-07 06:45:29 - browse：5347

Christine Kao/STAT

The biggest enticement that large pharmacy benefit managers offer to the employers that hire them is drug rebates — a steady stream of money sent back to their clients, a tangible symbol of the discounts that PBMs are able to wrangle out of pharmaceutical companies.

PBMs, the middlemen of drug pricing negotiations, also claim portions of those lucrative rebates for themselves. So when new market developments threaten to diminish or wipe away that revenue stream, PBMs find crafty ways to keep as much of those dollars as possible — often at the expense of employers.

One such case occurred last year, when a wave of Humira biosimilars entered the market and drug companies slashed the list prices of their insulin products. CVS Caremark, the PBM owned by CVS Health that oversees the prescription drug benefits of 103 million people, told its employer clients that it anticipated “more lower-cost products (including specialty biosimilars) may become preferred products” on its lists of approved drugs for 2024, according to documents obtained by STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Readout LOUD podcast: What to know about H5N1 bird flu

hotspot

WSS

How housing is health care on Long Island

Use wet bulb globe temperature, not heat index, to protect workers

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Will the IRA bring competition to the biologics market?

Long Covid needs a new name — and a new frame

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

entertainment

entertainment

focus

Medical leaders decry Supreme Court decision on affirmative action

Study: Adult vaccinations pay for themselves in societal benefits

Medical leaders decry Supreme Court decision on affirmative action

New Covid vaccine is recommended for everyone 6 months or older

Affirmative action in medical school literally saved lives

New weight loss drugs vying to be the next Wegovy or Mounjaro

In age of alternative facts, a scholarly course on calling out crap

WATCH: Why do bright lights make us see spots?

In age of alternative facts, a scholarly course on calling out crap

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Wikipedia

Regeneron agrees to White House price limits on anti

After gene therapy, two congenitally deaf children hear for the first time

Telehealth for opioid use disorder is lifesaving

How to make the FDA’s new prescription one

Acelyrin, a rare IPO success, stumbles in its first big test

What to make of Biden’s latest efforts on cancer research

hotspot

hotspot

focus

Wikipedia